Replies to post #141116 on Biotech Values

[DewDiligence]

2Q12 US Tysabri sales were $211M (+15% YoY, +5% QoQ), about 1/3 as much as US sales of Copaxone:

http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1717583

Teva will report 2Q12 US sales of Copaxone on 8/2/12.